A series of phosphonic analogues of tyrosine and 3,4-dihydroxyphenylalanine (dopa) were synthesized in order to study their interaction with mushroom tyrosinase. 1-Amino-2-(3,4-dihydroxyphenyl)ethylphosphonic acid and 1-amino-2-(3,4-dimethoxyphenyl)ethylphosphonic acid turned out to be substrates for mushroom tyrosinase with Km values of 3.3 mm and 9.3 mm respectively. Shortening of the alkyl chain by one methylene group gave amino-(3,4-dihydroxyphenyl)methylphosphonic acid, one of the most powerful known inhibitors of this enzyme. This compound, racemic as well as in its optically active forms, exerts a mixed type of inhibition with an affinity for the enzyme one order of magnitude greater than that of the natural substrate.
INTRODUCTION
there were published over 70 papers dealing with the interaction of enzymes with amino phosphonates, and over 50 enzymes have been examined. Most of the enzymes are those involved in the metabolism of amino acids, and the majority of the amino phosphonates examined are simple analogues of amino acid substrates (Hilderbrand et al., 1983) differing only in that a CO2H group has been replaced by P03H2 or related function. The inhibition frequently observed indicates that there is a structural antagonism between amino acids and their phosphonic counterparts and that numerous enzymes do recognize amino phosphonates as being more or less similar to the respective amino carboxylates. The most conspicuous examples are provided by the strong inhibition of glutamate-ammonia ligase (glutamine synthetase) (Meek & Villafranca, 1980; Lejczak et al., 1981; Leason et al., 1982) , dipeptidyl carboxypeptidase I (Petrillo & Spitzmiller, 1979) , adenylosuccinate lyase (Brand & Lowenstein, 1978) and alanine racemase (Adams et al., 1974; Lacoste et al., 1985) by compounds that differ from the respective substrates only by having a phosphonic or phosphinic acid function in place of a carboxylic group. Apparently these enzymes bind amino phosphonates preferentially over their amino carboxylate substrates.
Several examples indicate that many enzymes do not differentiate between CO2H and PO3H2 functions as concerns the binding to active sites (Anderson & Fowden, 1970; Lacoste et al., 1972; Biryukov et al., 1978; Brand & Lowenstein, 1978; Iron et al., 1981; Lejczak et al., 1985; Lacoste et al., 1985) .
These are rather remarkable findings, considering that CO2H and P03H2 differ substantially in a great many respects, including size (P03H2 is considerably larger), shape (flat CO2H versus tetrahedral PO3H2) and acidity (pK difference of at least 3 units).
In several instances it has been found that structural differences between phosphonic and carboxylic groups do not prevent amino phosphonates from serving as substrates for enzymes that normally utilize amino carboxylates (Cassaigne et The phosphonic analogue of tyrosine (Cassaigne et al., 1967; Iron et al., 1981) and the phosphonic analogue of dopa (3,4-dihydroxyphenylalanine) (Stringer et al., 1974) were found to be converted into melanin-like compounds by tyrosinase.
Tyrosinase (EC 1.14.18.1) is the main enzyme involved in the melanin biosynthesis, catalysing the two first reactions of the pathway. The first one is the ohydroxylation of monophenols (e.g. tyrosine) to odiphenols (e.g. dopa), and the second one is the four-electron oxidation of two dopa molecules, by using molecular 02, to dopaquinone, which undergoes fast chemical rearrangements into melanins according to the Raper-Mason scheme (Garcia-Carmona et al., 1982) .
In the present paper we introduce a series of amino phosphonates structurally related to tyrosine and dopa and study their effects on mushroom tyrosinase. We show that the true phosphonic analogue of dopa, 1-amino-2-(3,4,-dihydroxyphenyl)ethylphosphonic acid, serves as a substrate, the L-isomer being significantly better. Shortening by one methylene group led to amino-(3,4,-dihydroxyphenyl)methylphosphonic acid, a potent inhibitor. EXPERIMENTAL Chemicals and general methods L-3,4-Dihydroxyphenylalanine was from Reanal, Budapest, Hungary, and L-tyrosine was from Loba Chemie, Vienna, Austria.
All the starting materials and solvents used in this work were reagent grade, generally 98 % or higher purity, and were used without further purification. Proton-n.m.r. spectra were recorded on a Tesla BS 467 spectrometer for dilute solutions (10%), with hexamethyldisiloxane as internal standard. The structures of all the compounds were additionally supported by their i.r. (Perkin-Elmer 621) spectra and elemental analyses (N+0.3% and P + 0.3 % ). Melting points (uncorrected) were determined on a Koeffler apparatus. The yields given are based on isolated products after purification. Syntheses l-Amino-2-(3,4-dimethoxyphenyl)ethylphosphonic acid (compound II). The following modification of the method of Kowalik et al. (1981) was used. 3,4-Dimethoxyphenylacetic acid (91.8 g, 0.5 mol) was dissolved in chloroform (200 ml), and thionyl chloride (51 ml, 0.65 mol) was added. The mixture was refluxed for 1 h, and the volatile components were removed on a rotary evaporator. The crude 3,4-dimethoxyphenylacetyl chloride was then dissolved in diethyl ether (200 ml), cooled to -5°C, and triethyl phosphite (85 ml, 0.5 mol) was added dropwise. After 1 h at -5°C the precipitated enol of diethyl 1-oxo-2-(3,4-dimethoxyphenyl)ethylphosphonate was collected by filtration, immediately dissolved in a mixture of methanol (500 ml), hydroxylamine hydrochloride (35 g, 0.5 mol) and pyridine (41 ml, 0.5 mol) and stirred overnight at room temperature. The solvent was then removed in vacuo and the oily residue was dissolved in ice-cold 5% (w/v) HCl (100 ml). Diethyl 1-(Nhydroxyimino)-2-(3,4-dimethoxyphenyl)ethylphosphonate was extracted into chloroform (3 x 200 ml), and the combined extracts were washed successively with ice-cold water (50 ml portions) up to pH 6, and dried over anhydrous Na2SO4. The oily residue obtained after evaporation of the chloroform was dissolved in formic acid (400 ml), zinc powder (100 g) was added and the resulting mixture was stirred overnight. Excess of zinc and zinc formate were filtered off, solvent evaporated off in vacuo, and the residue was suspended in chloroform (500 ml) and neutralized with Na2CO3. Removal of solid components by filtration and evaporation of chloroform yielded crude diethyl 1-amino-2-(3,4-dimethoxyphenyl) ethylphosphonate (99 g, 0.32 mol), which was dissolved in dry diethyl ether (200 ml), and anhydrous oxalic acid (28.1 g, 0.32 mol) was added. The precipitated diethyl 1-amino-2-(3,4-dimethoxyphenyl)ethylphosphonate oxalate (compound I) (78.5 g, 39% yield) was of satisfactory purity: m.p. 126-127 "C, n.m.r. a (p.p.m.) (2H20) 1.18 (6H, t, J = 7.5 Hz, 2CH2CH3), 3.02 (2H, d-d, J = 7 Hz, J= 9 Hz, CH2CH), 3.69 (6H, s, 20CH3), 4.02 (5H, m, CHP+20CH2) and 6.78 (3H, broad s, C6H3).
Refluxing of compound (I) (8.2 g, 0.02 mol) in conc. HCl (100 ml) for 8 h, followed by evaporation, dissolution in ethanol (50 ml) and addition of pyridine (to pH 6) Enantiomers of the phosphonic analogue of dopa (compound III) were obtained by resolution of compound (I) with dibenzoyltartaric acid by triplicate crystallization from ethanol, a procedure analogous to that described by Kowalik et al. (1984) .
The use ofdibenzoyl-L( + )-tartaric acid afforded its salt Amino-(3,4dimethoxyphenyl)methylphosphonic acid (compound V). This was prepared by amidoalkylation of PCI3 with a mixture of 3,4-dimethoxybenzaldehyde, acetamide and acetyl chloride in acetic acid, a procedure analogous to that previously described for the phosphonic analogue of serine (Lejczak et al., 1984) , in 20% yield: m.p. 258-262 "C (decomp.), n.m.r. a (p.p.m.) (2H20/2H2SO4) 4.04 and 4.12 (3H, s, OCH3), 5.03 (1 H, d, J = 18 Hz, CHP) and 7.37 (3H, m, C613).
Amino-(4-methoxyphenyl)methylphosphonic acid (compound VI). This was prepared by a procedure analogous to that described by Lejczak et al. (1984) Amino43-methoxyphenyl)methylphosphonic acid (compound VII). This was prepared from 3-methoxybenzaldehyde, by a procedure analogous to that described by Lejczak et al. (1984) 1-Amino-2-(phenyl)ethylphosphonic acid (compound IX). This was prepared starting from phenylacetaldehyde, by a procedure analogous to that described by Lejczak et al. (1984) , in 33% yield: m.p. 247-249°C (decomp.) [literature (Chalmers & Kosolapoff, 1953) Amino-(3,4-dihydroxyphenyl)methylphosphonic acid (compound X). Refluxing of compound (V) (4.9 g, 0.02 mol) in 40% (w/v) HBr (100 ml) for 8 h, evaporation of the solvent in vacuo, dissolution of the oily residue in ethanol and precipitation of the product with pyridine (to achieve pH about 6) yielded 2.5 g (58% yield) of compound (X): m.p. 281-284°C (decomp.), n.m.r. a (p.p.m.) (2H20/2H2SO4) 5.16 (1H, d, J= 17.5 Hz, CHP) and 7.42 (3H, m, C6H3).
Enantiomers of compound (X) were obtained by the resolution of its diphenyl ester with dibenzoyl-L(+)-tartaric anhydride. Diphenyl amino-(3,4-dimethoxyphenyl)methylphosphonate hydrobromide (compound XI) was prepared by the procedure of Oleksyszyn et al. (1979) (3H, broad s, NH3+). This compound (8.6 g, 0.017 mol) was treated with dibenzoyl-L(+)-tartaric anhydride (5.8 g, 0.017 mol) as described previously (Kafarski et al., 1983 ) and the resulting amide was crystallized from diethyl ether (70 ml). The precipitate was recrystallized twice from diethyl ether, yielding 4.2 g (68% yield) of The configuration of amino phosphonate in compounds (XIIa) and (XIIb) was assigned tentatively on the basis of their spectral properties (Kafarski et al., 1982) . The enzyme was dissolved in 0.067 M-Na2HPO4/ KH2PO4 buffer, pH 6.8, to give a concentration of 10 mg/ml.
Unless otherwise indicated the activity of the enzyme was assayed in a reaction mixture of 2 ml that included 1 ml of tyrosine solution (to give a final concentration of 0.05-0.5 mM) or 1 ml of L-dopa solution (0.2-0.05 mM), 10,1 of enzyme (added last) and 0.067 M-phosphate buffer, pH 6.8, up to 2 ml. The reaction was carried out at 25 'C. The formation of dopachrome was monitored spectrophotometrically at 475 nm (Graham & Jeffs, 1977) 
RESULTS
The influence of phosphonic analogues of dopa and tyrosine on mushroom tyrosinase is summarized in Table 1 . The Km and the Ki values were determined for compounds exhibiting significant effects. Both isomers of the true phosphonic analogue of dopa, I-amino-2-(3,4-dihydroxyphenyl)ethylphosphonate (compound III) , are oxidized by the enzyme with different rates. The Km values were found to be 3.3 mm for the L-isomer (i.e. one order of magnitude higher than for natural substrates) and 34 mm for the D-isomer. This latter value may be misleading, because the optical purity of the D-isomer is 80%, and thus the Km value comes from the combined activities of the excess of D-isomer and its contamination with L-isomer. Also, I-amino-2-(3,4-dimethoxyphenyl)-ethylphosphonic acid (compound II) is easily oxidized by tyrosinase (Km 9.3 mM).
The Km measurements were based on an assumption that the phosphonic analogues of dopa react in the same manner as the natural substrate, and that the measurements at 475 nm correspond to the initial rate of production of the phosphonic analogue of dopachrome. Ki ( for the D-isomer (compound Illa) and the dimethoxy derivative (compound II) are significantly lower. Amino-(3,4-dihydroxyphenyl)methylphosphonic acid (compound X), the analogue of dopa shorter by one methylene group, turned out to be a potent inhibitor. Fig. 1 shows a Lineweaver-Burk plot and a Dixon plot for the inhibition of o-phenol oxidase activity by the L-isomer of the compound (X). The plots indicate a mixed type of inhibition. Both isomers of compound (X) and their racemic mixture influenced monophenol mono-oxygenase and o-phenol oxidase activities in the same manner, exerting mixed inhibition with the Ki values very close to each other, thus showing no stereochemical preference.
Other phosphonates studied (i.e. analogues of tyrosine and phenylalanine) exhibited only slight inhibitory effects. 
DISCUSSION
A simple replacement of carboxylic moieties of tyrosine (Cassaigne et al., 1967; Iron et al., 1981) and dopa (Stringer et al., 1974) by phosphonic groups led to compounds that serve as substrates for tyrosinase. To complete the data we have synthesized the optical isomers of the phosphonic analogue of dopa and evaluated their action towards mushroom tyrosinase.
Thus racemic 1-amino-2-(3,4-dihydroxyphenyl)ethylphosphonic acid (compound III), the true analogue of dopa, binds to the enzyme with an affinity one order of magnitude lower than the natural substrate (Km 3.3 mm compared with 0.5 mm for dopa). These results agree well with those obtained by Iron et al. (1981) , who showed that the phosphonic analogue of tyrosine has an affinity for the enzyme lower than the natural substrate (Km 8 mM; Km for tyrosine 0.3 mM). We have shown that the L-isomer of compound (III) (Km 3.3 mM) binds to tyrosinase preferentially to its D-form (Km 34 mM).
Further modification of this structure consisting in replacement of hydroxy by methoxy substituents in the aromatic ring led to 1-amino-2-(3,4-dimethoxyphenyl)-ethylphosphonic acid (compound II), which is also oxidized by the enzyme, although it is a worse substrate (Km 9.3 mM) than compound (III). The substrate activity of the dimethoxy derivative is not surprising, since it has been shown that chemical oxidation of catechols and the corresponding dimethoxy aromatics gives the same quinones (Syper et al., 1985) .
The fact that compounds (II) and (III) serve as substrates for tyrosinase (and do not act as inhibitors) indicates that this enzyme does not differentiate between CO2H and P03H2 functions.
A significant change in activity was achieved by shortening the alkyl chain of compounds (II) and (III) by one methylene group. Amino-(3,4-dimethoxyphenyl)-methylphosphonic acid (compound V) and amino-(3,4-dihydroxyphenyl)methylphosphonic acid (compound X) obtained in this manner are unable to undergo ring closure to form the analogues of leucodopachrome and dopachrome after enzymic oxidation. Thus they may serve as false substrates for tyrosinase.
Compound (X) is one of the most powerful inhibitors of tyrosinase, nearly equipotent to L-mimosine and tropolone , and similarly exhibiting a mixed type of inhibition. It is clear that effectiveness of the inhibitor depends on the substrate: inhibition is higher with tyrosine than with dopa. In contrast with the action of the true analogue of dopa (compound III), the mode of activity and affinity towards the enzyme is not dependent on the configuration of inhibitor (i.e. no stereoselectivity was observed). Fig. 2 shows a schematic model of the active site of tyrosinase, and the proposed binding mode of the substrates (dopa and its true phosphonic analogue are bound in the same manner) and both isomeric forms of inhibitor. It appears that the inhibitor is too short to fit at the active centre in the manner of substrate. We propose that it is preferentially bound in the hydrophobic catechol-binding site. molecules should be recognized as substrates. Thus the inhibition that we observe requires additional explanations. Tyrosinase is copper-containing enzyme of quite complicated mechanism of action (Galindo et al., 1983) , in which copper serves as electron carrier (Jolley et al., 1974; . On the other hand amino phosphonates are strong complexing agents (Redmore, 1976) . The mixed type of inhibition exerted by compound (X) may come from its ability to chelate copper at the active site and its ability to bind to that portion of the enzyme that normally binds the substrate. To obtain further information on the mechanism of inhibition we compared the effectiveness of compound (X) as inhibitor in the presence and in the absence of CuS04. Fig. 3 shows that upon addition of CuS04 at various concentrations the monophenol mono-oxygenase activity of phosphonate-inhibited enzyme was recovered to some extent, with maximum observed recovery achieved at 0.2-0.4mM-CuS04. Only a slight effect of Cu2+ on o-phenol oxidase activity of phosphonate-inhibited enzyme was observed. Further experiments showed that brief preincubation (5 min) of compound (X) with an equimolar concentration (0.5 mM) of CuS04 before the addition of mushroom tyrosinase does not influence the inhibitory effect. Thus it seems unlikely that a simple chelation effect is responsible for the inhibitory action. Perhaps the interaction between Cu2+ and phosphonic inhibitor is enzyme-specific, reflecting the particular microenvironment of bound metal ion and its role in the catalytic action of the enzyme.
Amino-(3,4-dimethoxyphenyl)methylphosphonic acid (compound V) and phosphonic analogues of tyrosine (compounds XIII and XIV) exhibit weak inhibitory effects towards tyrosinase. This is of particular interest in the case of compound (V), which should exhibit similar action to compound (X). This may be due to the fact that compound (X) does not cause inhibition in its intact form, but may be oxidized to some extent, for example to dopasemiquinone (Chedekel et al., 1984) , and the oxidized form is responsible for the inhibition. The quite weak inhibitory activities of phosphonic analogues of tyrosine and phenylalanine (compounds VIII and IX) support this idea. To exert their inhibitory effect in this manner o-hydroxylation before the oxidation step is required.
